Finasteride 98319-26-7
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight:
372.54 Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Biological Activity
Finasteride
binds to the type 2 isozyme-NADPH complex to form a ternary complex
with Ki of 1.19 nM, which then rearranges to a high affinity complex
(E:I) with a pseudo first order rate constant of 1.62 ms. Finasteride dose-dependently inhibits the growth rate of the LnCap cell line. Finasteride markedly inhibits prostate-specific antigen (PSA) secretion and expression in LNCaP cells.
Finasteride induces dosage-related incidences of hypospadias
(penischisis) in male offspring with a threshold dosage level near 0.1
mg/kg/day and a 100% effect level of 100 mg/kg/day in male rats.
Finasteride also causes decreased anogenital distance in male offspring
in male rats. Finasteride and castration decreases
prostate weight at day 21 by 65% and 93%, respectively, in rats.
Finasteride has no significant effect on DNA content after 4 days and
decreases DNA content by a maximum of 52% at 14 days in rats.
Finasteride causes a less intense increase in staining in which 16% of
epithelial cells stained for tissue transglutaminase on day 9 with a
return to baseline by day 14 in rats. Finasteride-induced staining is
less intense with peak staining at day 4 (0.7% of epithelial cells) and a
return to control values by day 9 in rats.
Contact us if you need more details on 98319-26-7. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Finasteride 98319-26-7、98319-26-7 Finasteride. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight:
372.54 Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Biological Activity
Finasteride
binds to the type 2 isozyme-NADPH complex to form a ternary complex
with Ki of 1.19 nM, which then rearranges to a high affinity complex
(E:I) with a pseudo first order rate constant of 1.62 ms. Finasteride dose-dependently inhibits the growth rate of the LnCap cell line. Finasteride markedly inhibits prostate-specific antigen (PSA) secretion and expression in LNCaP cells.
Finasteride induces dosage-related incidences of hypospadias
(penischisis) in male offspring with a threshold dosage level near 0.1
mg/kg/day and a 100% effect level of 100 mg/kg/day in male rats.
Finasteride also causes decreased anogenital distance in male offspring
in male rats. Finasteride and castration decreases
prostate weight at day 21 by 65% and 93%, respectively, in rats.
Finasteride has no significant effect on DNA content after 4 days and
decreases DNA content by a maximum of 52% at 14 days in rats.
Finasteride causes a less intense increase in staining in which 16% of
epithelial cells stained for tissue transglutaminase on day 9 with a
return to baseline by day 14 in rats. Finasteride-induced staining is
less intense with peak staining at day 4 (0.7% of epithelial cells) and a
return to control values by day 9 in rats.
Contact us if you need more details on 98319-26-7. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Finasteride 98319-26-7、98319-26-7 Finasteride. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Endocrinology & Hormones > 5-alpha Reductase Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9